OSLO, Norway, Feb. 21, 2020 /PRNewswire/ -- Nordic Nanovector
ASA (OSE: NANO) announces that it will report its results for the
fourth quarter and full year 2019 on Thursday, 27 February
2020. A presentation by Nordic Nanovector's senior management
team will take place at 8:30am CET
at:
Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo
Meeting Room: VIPPETANGEN
The presentation will be recorded as a webcast and will be
available at www.nordicnanovector.com in the section:
Investors & Media
The results report and the presentation will be available at
www.nordicnanovector.com in the section: Investors &
Media/Reports and Presentation/Interim Reports/2019 from
7:00am CET the same day.
For further information, please contact:
IR enquiries
Malene Brondberg, VP Investor
Relations and Corporate Communications
Cell:
+44-7561-431-762
Email:
ir@nordicnanovector.com
About Nordic Nanovector:
Nordic Nanovector is committed to develop and deliver innovative
therapies to patients to address major unmet medical needs and
advance cancer care. The Company aspires to become a leader in the
development of targeted therapies for haematological cancers.
Nordic Nanovector's lead clinical-stage candidate is
Betalutin®, a novel CD37-targeting radioimmunotherapy
designed to advance the treatment of non-Hodgkin's lymphoma (NHL).
NHL is an indication with substantial unmet medical need,
representing a growing market forecast to be worth nearly
USD 29 billion by 2026. Nordic
Nanovector intends to retain marketing rights and to actively
participate in the commercialisation of Betalutin® in
core markets.
Further information can be found at
www.nordicnanovector.com.
This information is subject to a duty of disclosure pursuant
to Sections 4-2 and 5-12 of the Securities Trading Act.
CONTACT:
Media Enquiries
Mark Swallow/Frazer
Hall/David Dible (Citigate Dewe
Rogerson)
Tel: +44-207-638-9571
Email:
nordicnanovector@citigatedewerogerson.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/nordic-nanovector/r/nordic-nanovector-asa--invitation-to-fourth-quarter-and-full-year-2019-results-presentation-and-webc,c3041894
View original
content:http://www.prnewswire.com/news-releases/nordic-nanovector-asa-invitation-to-fourth-quarter-and-full-year-2019-results-presentation-and-webcast-301009191.html
SOURCE Nordic Nanovector